ZA958173B - Use of a serotonin agoinist in combination with a tachykinin receptor antaonist in the treatment or prevention of migraine - Google Patents

Use of a serotonin agoinist in combination with a tachykinin receptor antaonist in the treatment or prevention of migraine

Info

Publication number
ZA958173B
ZA958173B ZA958173A ZA958173A ZA958173B ZA 958173 B ZA958173 B ZA 958173B ZA 958173 A ZA958173 A ZA 958173A ZA 958173 A ZA958173 A ZA 958173A ZA 958173 B ZA958173 B ZA 958173B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
combination
serotonin
antaonist
Prior art date
Application number
ZA958173A
Other languages
English (en)
Inventor
Marlene Lois Cohen
Kirk Willis Johnson
Lee Alan Phebus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA958173B publication Critical patent/ZA958173B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA958173A 1994-10-05 1995-09-28 Use of a serotonin agoinist in combination with a tachykinin receptor antaonist in the treatment or prevention of migraine ZA958173B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/318,391 US5744482A (en) 1994-10-05 1994-10-05 Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine

Publications (1)

Publication Number Publication Date
ZA958173B true ZA958173B (en) 1997-04-01

Family

ID=23237987

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958173A ZA958173B (en) 1994-10-05 1995-09-28 Use of a serotonin agoinist in combination with a tachykinin receptor antaonist in the treatment or prevention of migraine

Country Status (12)

Country Link
US (1) US5744482A (el)
EP (1) EP0710479B1 (el)
AT (1) ATE175347T1 (el)
AU (1) AU4130196A (el)
DE (1) DE69507112T2 (el)
DK (1) DK0710479T3 (el)
ES (1) ES2125567T3 (el)
GR (1) GR3029666T3 (el)
IL (1) IL115451A0 (el)
SI (1) SI0710479T1 (el)
WO (1) WO1996011000A1 (el)
ZA (1) ZA958173B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US6492332B1 (en) * 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US20040127884A1 (en) * 1994-12-12 2004-07-01 Omeros Corporation Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
AU4467396A (en) 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
ES2244966T3 (es) * 1994-12-12 2005-12-16 Omeros Corporation Solucion de irrigacion y su utilizacion para inhibir perioperatoriamente el dolor, la inflamacion y el espasmo en una herida.
AU5966196A (en) * 1995-06-08 1997-01-09 Eli Lilly And Company Methods of treating cold and allergic rhinitis
US6413961B1 (en) * 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
WO1998011895A1 (en) * 1996-09-18 1998-03-26 Eli Lilly And Company A method for the prevention of migraine
GB9620777D0 (en) * 1996-10-07 1996-11-20 Merck Sharp & Dohme Therapeutic use
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
DE19917347A1 (de) * 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
JP2001172178A (ja) * 1999-10-25 2001-06-26 Pfizer Prod Inc 偏頭痛治療用のｎｋ−１レセプターアンタゴニスト及びエレトリプタン
AUPQ514600A0 (en) * 2000-01-18 2000-02-10 James Cook University Brain injury treatment
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
ES2421511T3 (es) 2001-12-21 2013-09-03 X Ceptor Therapeutics Inc Moduladores de LXR
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004112723A2 (en) * 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US20050282879A1 (en) * 2004-06-17 2005-12-22 Foad Salehani Methods and composition for treatment of migraine and symptoms thereof
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
RU2010114003A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение пептида фолликулярного гонадолиберина в качестве терапевтического средства при лечении инфекции streptococcus pneumoniae

Also Published As

Publication number Publication date
EP0710479A1 (en) 1996-05-08
GR3029666T3 (en) 1999-06-30
DE69507112D1 (de) 1999-02-18
WO1996011000A1 (en) 1996-04-18
ATE175347T1 (de) 1999-01-15
IL115451A0 (en) 1995-09-28
DE69507112T2 (de) 1999-06-10
AU4130196A (en) 1996-05-02
SI0710479T1 (en) 1999-06-30
US5744482A (en) 1998-04-28
EP0710479B1 (en) 1999-01-07
ES2125567T3 (es) 1999-03-01
DK0710479T3 (da) 1999-08-30

Similar Documents

Publication Publication Date Title
IL115451A0 (en) Use of a serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine
DE69734006D1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda-antagonist
IL142921A0 (en) USES FOR Eph RECEPTOR ANTAGONISTS AND AGONISTS TO TREAT VASCULAR DISORDERS
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
AP2002002642A0 (en) A phamaceutical composition for treatment of acute, chronic pain and/ or neuropathic pain and migraines
BR0106462A (pt) Composições farmacêuticas para distúrbios do snc e outros distúrbios
BR0200283A (pt) Composições farmacêuticas para o tratamento de distúrbios do snc e de outros distúrbios
BE2013C064I2 (el)
YU7699A (sh) Lečenje prehlade ili alergijskog rinitisa
EP0832650A3 (en) Use of serotonin 5-HT1F agonists for the prevention of migraine
EP1064966A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
WO2001045684A3 (en) Formulations of adenosine a1 agonists
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
EP0976747A3 (en) Use of 5HT-1F receptor antagonists for treating anxiety disorders
EP1064948A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
EP0797994A3 (en) Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings
BR9907896A (pt) "combinação de um antagÈnico alfa-adrenérgico e de um agente doador de óxido de nitrogênio para o tratamento de disfunções sexuais femininas"
EP1051994A3 (en) 5HT1 receptor agonists and a COX-2 inhibitor for the treatment of migraine
EP1508337A3 (en) Uses for eph receptor antagonists and agonists to treat vascular disorders
DE60008589D1 (de) Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten
DK0942729T3 (da) Anvendelse af NK-1-receptorantagonister til behandling af stresslidelser
BR9507848A (pt) Composição farmcéutica contendo espiramicina eventualmente em associação com o metronizadol
IT1274012B (it) N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina
DK1128833T3 (da) Anvendelse af agonister af corticosteroidreceptorer og et misbrugsstof til behandling af misbrug